The HBV seroprevalence and immune responses to hepatitis B vaccination among college students from four universities in China
The HBsAg prevalence among college students has been significantly reduced after the integration of hepatitis B vaccine into Expanded Program on Immunization, but the rate of seroprotective anti-HBs among these students remains low. Hepatitis B vaccination or booster dose is advised for a high-risk group who have negative anti-HBs, and two doses of hepatitis B vaccine are advised for those with anti-HBs < 2 mIU/mL.
Authors
- Xingyan Xu (ORCID: https://orcid.org/0000-0002-4802-8542)
- Pan‐Chyr Yang (ORCID: https://orcid.org/0000-0001-6330-6048)
- Changhong Du (ORCID: https://orcid.org/0000-0002-1537-0325)
- Minmin Liu (ORCID: https://orcid.org/0000-0001-9391-7739)
- Yarong Song (ORCID: https://orcid.org/0000-0003-0032-813X)
- Yongliang Feng (ORCID: https://orcid.org/0000-0003-0088-585X)
- Feng Jiang
- Lili Li (ORCID: https://orcid.org/0000-0002-0292-5889)
- Yao Tian (ORCID: https://orcid.org/0009-0003-9107-5269)
- Jie Li (ORCID: https://orcid.org/0000-0003-0973-8645)
- Jie Wang (ORCID: https://orcid.org/0000-0001-6518-948X)
- Le Yang
- Jing Shi (ORCID: https://orcid.org/0000-0001-8355-2502)
- Guoping Zhang (ORCID: https://orcid.org/0000-0002-9042-2607)
- Huangyuan Li
- Qiong Li (ORCID: https://orcid.org/0000-0002-5625-7396)
- J.W. Qiao (ORCID: https://orcid.org/0000-0003-1151-9396)
Institutions
- Fujian Medical University (CN)
- China West Normal University (CN)
- Shanxi Medical University (CN)
- Peking University (CN)
- First Hospital of Shanxi Medical University (CN)
- Henan Provincial Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- Vaccine
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1016/j.vaccine.2025.127408
- Citations
- 2
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- National Key Research and Development Program of China